ALB and cystic fibrosis: Future modifications of SCFM-series ASM will need to consider nutrients and macromolecules in the CF lung environment that are not present in the current formulations, including bovine serum albumin (BSA), protein-bound iron sources (e.g., ferritin), and bioactive lipids.